Distribution and drug resistance analysis of pathogenic bacteria of bloodstream infection in hospitalized patients with hematological diseases from 2019 to 2021
The battle of bacteria|更新时间:2025-10-21
|
Distribution and drug resistance analysis of pathogenic bacteria of bloodstream infection in hospitalized patients with hematological diseases from 2019 to 2021
Journal of Chongqing Medical UniversityVol. 47, Issue 8, Pages: 1000-1004(2022)
Li Haolian,Zeng Lijun,Xu Jianmin,et al.Distribution and drug resistance analysis of pathogenic bacteria of bloodstream infection in hospitalized patients with hematological diseases from 2019 to 2021[J].Journal of Chongqing Medical University,2022,47(8):1000-1004.
Li Haolian,Zeng Lijun,Xu Jianmin,et al.Distribution and drug resistance analysis of pathogenic bacteria of bloodstream infection in hospitalized patients with hematological diseases from 2019 to 2021[J].Journal of Chongqing Medical University,2022,47(8):1000-1004. DOI: 10.13406/j.cnki.cyxb.003074.
Distribution and drug resistance analysis of pathogenic bacteria of bloodstream infection in hospitalized patients with hematological diseases from 2019 to 2021
To analyze the distribution characteristics and drug resistance of pathogenic bacteria of bloodstream infection in hospitalized patients with hematological diseases in Chinese PLA General Hospital,and to provide reference for the rational selection of antibiotics during clinical treatment.
Methods
2
A retrospective study was performed by reviewing the results of blood culture and drug susceptibility of hospitalized patients with hematological and non-hematological diseases from 2019 to 2021. VITEK-2 system was used for identification and antimicrobial susceptibility test.
Results
2
Gram-negative bacilli(71.2%) were the main pathogenic bacteria in patients with hematological diseases suffered from bloodstream infection,followed by gram-positive bacteria(26.8%) and fungi(2.0%). The main pathogens were
Escherichia coli
,
Klebsiella pneumoniae
,coagulase-negative
staphylococcus
,
Pseudomonas aeruginosa
,etc. The main gram-negative isolates were more sensitive to amikacin,imipenem and meropenem, those main gram-positive ones to vancomycin and linezolid,and fungal isolates to amphotericin B and voriconazole.
Staphylococcus
were not resistant to vancomycin,tigecycline or linezolid. Comparison was made between the pathogens of bloodstream infection in patients with hematological diseases and those with non-hematological diseases,which found that the proportion of
Pseudomonas aeruginosa
and
Stenotrophomonas maltophilia
was significantly higher in the former,while that of coagulase-negative
Staphylococci
and
Candida albicans
was significantly lower(
P
<
0.05). The resistance rate of
Escherichia coli
to carbapenems and quinolones in patients with hematological diseases was higher than that of patients with non-hematological diseases,and the difference was statistically significant(
P
<
0.05);the resistance rate of
Klebsiella pneumoniae
and
Pseudomonas aeruginosa
to antibacterial drugs such as carbapenems and quinolones was lower than that of patients with non-hematological diseases, and the difference was statistically significant(
P
<
0.05).
Conclusion
2
Gram-negative bacteria are the most common pathogens causing bloodstream infection in patients with hematological diseases,especially
Escherichia coli
, which is nearly the same to that in patients with non-hematological diseases in our hospital. Gram-negative bacteria have high sensitivity to amikacin,imipenem,meropenem,piperacillin/tazobactam,and gram-positive bacteria have high sensitivity to vancomycin and linezolid. This study finds that the drug resistance rate of
Escherichia coli
to carbapenems and qui
nolones in patients with hematological diseases was higher than that of patients with non-hematological diseases,and the attention and monitoring of carbapenems and quinolones should be strengthened in clinical diagnosis and treatment. Timely monitoring of pathogens and drug resistance,reasonable selection of antibiotics, and early control of bloodstream infections are very important for prognosis.
Zhou ML , Yang QW , Yu SY , et al . Updates on the epidemiology of bloodstream infection [J ] . Chin J Infect Chemother , 2019 , 19 ( 2 ): 212 -
Allegra A , Innao V , Penna G , et al . Telomerase and telomere biology in hematological diseases:a new therapeutic target [J ] . Leuk Res , 2017 , 56 : 60 - 74 .
Jian JY , Xie ZQ , Quan XX , et al . Distribution and antimicrobial resistance of pathogenic bacteria from blood infections [J ] . Chin J Nosocomiol , 2017 , 27 ( 3 ): 535 - 538 .
Li L , Zhou M , Qiao D , et al . Pathogenic distribution and drug resistance analysis of secondary infection in malignant hematological diseases [J ] . Lab Med , 2020 , 35 ( 3 ): 189 - 194 .
Li MY , Wang JH , Wang JG , et al . Distribution and drug resistance of pathogenic bacteria in blood stream infection of inpatients with hematological diseases [J ] . Clin J Med Off , 2021 , 49 ( 11 ): 1261 - 1263 .
Xu NF , Tang XQ , Mao M , et al . A distribution and resistance analysis of pathogens of blood flow infection in hematpatients during 2017-2020 [J ] . Labeled Immunoass Clin Med , 2021 , 28 ( 9 ): 1515 - 1520 .
Yu GP , Yin XM , Lai SF , et al . An analysis of distribution and drug resistance of pathogens in blood culture positive samples in a hospital in 2020 [J ] . Labeled Immunoass Clin Med , 2021 , 28 ( 4 ): 600 - 603,670 .
Zhang GY , Wu YD , Xie SF , et al . Distribution and antimicrobial resistance of pathogens causing bloodstream infection in patients with hematological diseases in 2012-2016 [J ] . Chin J Infect Control , 2018 , 17 ( 10 ): 853 - 859 .